Ameela Exosomes
£101.99 inc. VAT
Categories:
Ameela Exosomes is a regenerative exosome treatment formulated to support skin rejuvenation and hair restoration by delivering powerful growth factors and signalling molecules that promote repair and regeneration.
Description
Ameela Exosomes is an advanced regenerative treatment designed to support skin rejuvenation, repair, and hair restoration. Powered by high-quality biomimetic exosomes, this innovative formula delivers a concentrated blend of growth factors, peptides, amino acids, and signalling molecules that help stimulate cellular communication and accelerate tissue regeneration.
Suitable for use following microneedling, mesotherapy, and other aesthetic procedures, Ameela Exosomes can help improve skin texture, elasticity, hydration, and overall radiance while also supporting scalp health and promoting stronger, healthier hair growth.
Manufactured to stringent quality standards, Ameela Exosomes offers practitioners a cutting-edge solution for addressing concerns such as ageing skin, inflammation, pigmentation, acne scarring, and hair thinning.
Key Features
- Advanced exosome-based regenerative formula
- Supports skin rejuvenation and hair restoration
- Rich in growth factors, peptides, amino acids, and signalling molecules
- Helps improve texture, hydration, elasticity, and radiance
- Suitable for microneedling and mesotherapy protocols
- Can be used to address acne scars, pigmentation, inflammation, and hair thinning
- Sterile and practitioner-only treatment
- Manufactured to high quality standards
Ameela Exosomes is an ideal addition to modern aesthetic clinics looking to offer innovative regenerative treatments with minimal downtime and impressive results.
DISCLAIMER
This product is a prescription-grade injectable medical device intended for use by qualified aesthetic practitioners only. By purchasing this item, you confirm that you are a trained and insured professional and that it will be used in a clinical setting in accordance with manufacturer guidelines.
